PET scans to check Trop2 ADC treatment in breast cancer
Part of Cancer, Skin clinical trials.
This trial uses a special PET scan to see if a type of drug called Trop2-ADC is working in people with advanced breast cancer. The scan may help doctors decide if the treatment is right for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults age 18 or older with advanced breast cancer that has spread and been previously treated with systemic therapy
- At least one tumor that can be measured on a standard scan like CT or MRI
- Willing to have two PET scans with a radioactive tracer before and during treatment with Trop2-ADC
- Able to perform daily activities with minimal help (ECOG score 0-1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special PET/CT scan can show how well a Trop2-targeting drug is working in people with advanced lung cancer that has already been treated. It aims to improve how we monitor treatment response.
This study tests whether a new imaging agent called 68Ga-MY6349 can help detect tumors during a PET/CT scan. If you are an adult with a solid tumor (newly diagnosed or already treated), you may be able to take part in this research to see if the new tracer works better than standard imaging.
This trial tests a new imaging scan (two types of PET/CT) to see how well it tracks tumor response to a TROP2-targeted drug in people with EGFR-mutant lung cancer that stopped responding to standard pills. It aims to improve how doctors measure treatment success.
This trial tests a new imaging agent (99mTc-MY6349) to see if it can detect Trop2, a protein found on some breast cancer cells. It may help doctors better see and understand triple-negative breast cancer that has spread.
This study uses a special scan (molecular imaging) to see how well antibody-drug conjugates (ADCs) work in people with breast cancer. It may help doctors choose the right treatment for you.
This study tests a new type of PET scan (a specialized imaging test) to see if it can predict whether chemotherapy will work for HER2-positive breast cancer before surgery. The scan uses a radioactive tracer designed to highlight HER2-positive cancer cells, helping doctors personalize your treatment plan.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.